KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Sarepta Therapeutics (SRPT) over the last 14 years, with Q2 2025 value amounting to $38.1 million.

  • Sarepta Therapeutics' Non Operating Income rose 16657.09% to $38.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $74.2 million, marking a year-over-year increase of 20621.42%. This contributed to the annual value of $42.7 million for FY2024, which is 11692.33% up from last year.
  • According to the latest figures from Q2 2025, Sarepta Therapeutics' Non Operating Income is $38.1 million, which was up 16657.09% from $10.1 million recorded in Q4 2024.
  • Over the past 5 years, Sarepta Therapeutics' Non Operating Income peaked at $118.9 million during Q2 2023, and registered a low of -$374.6 million during Q1 2023.
  • For the 5-year period, Sarepta Therapeutics' Non Operating Income averaged around -$22.7 million, with its median value being $5.5 million (2022).
  • The largest annual percentage gain for Sarepta Therapeutics' Non Operating Income in the last 5 years was 80122.04% (2023), contrasted with its biggest fall of 206983.49% (2023).
  • Over the past 5 years, Sarepta Therapeutics' Non Operating Income (Quarter) stood at -$118.1 million in 2021, then soared by 104.68% to $5.5 million in 2022, then skyrocketed by 184.89% to $15.7 million in 2023, then crashed by 36.1% to $10.1 million in 2024, then surged by 278.26% to $38.1 million in 2025.
  • Its Non Operating Income stands at $38.1 million for Q2 2025, versus $10.1 million for Q4 2024 and $11.8 million for Q3 2024.